How to make oral drugs more efficient; CEA-Leti unveils nanocarrier IBS treatment;

> Of all the drug delivery methods, oral is the most popular. However, not all drugs are most efficient when delivered orally. Poor bioavailability means higher-than-required oral doses, leading to waste, risk of toxicity and other problems. Researchers in South Africa take a look at different approaches for enhancement of oral drug bioavailability. Abstract

> The French research center CEA-Leti has unveiled a program to use a nanocarrier-based method to help treat inflammatory bowel disease. The Delivering Nano-pharmaceuticals through Biological Barriers project (BIBA) has eight partners in France, Germany, Spain and Switzerland. Story

> Idera Pharmaceuticals says its gene-silencing oglionucleotide (GSO) technology has something that other gene-silencing methods do not: With GSOs, there is no need for a delivery technology. Idera release

And Finally... Dispense my meds, HAL...HAL? More here

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.